Local transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus in Singapore has been reported.[1] As the pandemic spreads globally, increased utilization and shortages of personal protective equipment (PPE) are expected. Although extended PPE use would mitigate utilization rate, its safety is unknown. At the National Centre for Infectious Diseases, recommendations for healthcare workers (HCWs) in contact with known or suspected patients are in concordance with the US Centers for Disease Control and Prevention, which recommends gloves, gown, respiratory protection (eg, disposable N95 respirator), and eye protection (eg, goggles or disposable face shield), without the use of shoe covers.[2]An initial pilot study showed no contamination of N95 and disposable face visors after patient care, although in 1 instance, SARS-CoV-2 nucleic acid was detected on the front surface of an HCW’s shoe.[3] To evaluate the safety of extended PPE use, we conducted a 1-day PPE sampling study on HCWs caring for confirmed COVID-19patients to ascertain the per contact episode risk of PPE contamination with SARS-CoV-2.
Methods
The PPE samples were collected by 5 trained personnel using a standardized technique with Puritan EnviroMax Plus premoistened sterile swabs (Puritan Medical Products, Guilford, ME) from the entire front of goggles, the front surface of N95 respirator, and the front surfaces of shoes of 30 HCWs (Table 1) exiting patient rooms. Gloves and gowns were not swabbed because these are disposed after each use. Data on HCW category and details of activity in the room were recorded. Patients with positive SARS-CoV-2 PCR assays within the prior 48 hours were selected, and clinical data (ie, day of illness, presence of symptoms, and cycle threshold [Ct] value of clinical PCR) were obtained from the medical record. Environmental samples were tested using specific real-time RT-PCR methods targeting the SARS-CoV-2 RNA-dependent RNA polymerase (RdRP) and E genes.[4]
Table 1.
Characteristics of PPE Samples Collected and Relevant Patient Clinical Data
Sample No.
Staff Type
Duration of Time, Minutes
Activity
Clinical Data of Patient
Day of Illness
Symptomatic
Ct Value
1
Doctor
5
Examination
14
No
31.59
2
Doctor
5
Examination
9
Yes
20.80
3
Doctor
10
Communication without examination
9
Yes
20.80
4
Doctor
25
Examination
4
Yes
27.69
5
Doctor
6
Examination
8
Yes
30.7
6
Doctor
6
Examination
15
Yes
29.51
7
Doctor
8
Examination
19
Yes
30.24
8
Doctor
3
Examination
19
No
29.86
9
Doctor
11
Examination
15
No
31.4
10
Doctor
7
Examination
18
No
28.32
11
Doctor
5
Examination
14
Yes
29.02
12
Doctor
15
Examination
8
Yes
27.86
13
Doctor
20
Examination
8
Yes
27.86
14
Doctor
6
Examination
12
Yes
36.95
15
Doctor
10
Examination
10
No
31.33
16
Nurse
7
Collecting respiratory specimen
14
No
31.59
17
Nurse
5
Administering medications and communicating with patient
4
Yes
27.69
18
Nurse
18
Blood taking and communicating with patient
8
Yes
30.7
19
Nurse
19
Blood taking and collecting respiratory specimen
8
Yes
30.7
20
Nurse
4
Changing of wrist tag and collection of stool sample
15
Yes
29.51
21
Nurse
5
Collecting respiratory sample
18
No
28.32
22
Nurse
7
Collecting respiratory sample
19
Yes
30.24
23
Nurse
10
Administering medications
8
Yes
27.86
24
Nurse
5
Administering medications
20
Yes
29.91
25
Nurse
5
Monitoring vitals
15
Yes
32.23
26
Cleaner
5
Cleaning of high-touch areas
14
No
31.59
27
Cleaner
7
Cleaning of high-touch areas
9
Yes
20.80
28
Cleaner
2
Clearing trash
18
No
28.32
29
Cleaner
3
Clearing trash
15
No
31.4
30
Cleaner
3
Clearing trash
19
No
29.86
Note. Ct, cycle threshold. Cycle threshold refers to the number of cycles required for the fluorescent signal to cross the threshold in RT-PCR; a lower cycle threshold value indicates a higher viral load.
Characteristics of PPE Samples Collected and Relevant Patient Clinical DataNote. Ct, cycle threshold. Cycle threshold refers to the number of cycles required for the fluorescent signal to cross the threshold in RT-PCR; a lower cycle threshold value indicates a higher viral load.
Results
In total, 15 patients (7 women and 8 men) were selected. Patient characteristics varied by day of illness (median, day 14; interquartile range [IQR], 8.25–17.25), presence of symptoms (63% symptomatic), and clinical PCR Ct value (median, 30.08; IQR 28.85–30.86). No patient required ventilatory support and no aerosol-generating procedures were carried out prior to or during sampling. All 90 samples from 30 HCWs (doctors, nurses, and cleaners) were negative (Table 1). The median time spent in the patient’s room overall was 6 minutes (IQR, 5–10): 8 minutes for doctors, 7 minutes for nurses, and 3 minutes for cleaning staff. Activities ranged from casual contact (eg, administering medications or cleaning) to closer contact (eg, physical examination or collection of respiratory samples).
Discussion
Our study had several limitations. One limitation of our study was the use of surface swabs for sampling the surface of N95 masks rather than processing masks in extraction buffers with detergents, which is a method that has been used for isolation of influenza from N95 respirators.[5] Surface swabbing may be insufficient for the detection of entrapped viral particles. Second, all patients were in airborne infection isolation rooms with 12 air exchanges per hour, and these results may not be generalizable to other room configurations. Third, we did not assess the concomitant level of viral contamination of the environment in this study to correlate with the level of PPE contamination.Previous laboratory studies have demonstrated that viruses, such as SARS-CoV and human coronavirus 229E, can remain viable on PPE items, including latex gloves and disposable gowns,[6-8] but these studies were not performed in clinical settings. Despite the potential for extensive environmental contamination by SARS-CoV-2, we did not find similar contamination of PPE after patient contact. These results provide assurance that extended use of N95 and goggles with strict adherence to environmental and hand hygiene while managing SARS-CoV-2patients could be a safe option.
Authors: Francoise M Blachere; William G Lindsley; Cynthia M McMillen; Donald H Beezhold; Edward M Fisher; Ronald E Shaffer; John D Noti Journal: J Virol Methods Date: 2018-07-17 Impact factor: 2.014
Authors: Sean Wei Xiang Ong; Yian Kim Tan; Po Ying Chia; Tau Hong Lee; Oon Tek Ng; Michelle Su Yen Wong; Kalisvar Marimuthu Journal: JAMA Date: 2020-04-28 Impact factor: 56.272
Authors: Victor M Corman; Olfert Landt; Marco Kaiser; Richard Molenkamp; Adam Meijer; Daniel Kw Chu; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Marie Luisa Schmidt; Daphne Gjc Mulders; Bart L Haagmans; Bas van der Veer; Sharon van den Brink; Lisa Wijsman; Gabriel Goderski; Jean-Louis Romette; Joanna Ellis; Maria Zambon; Malik Peiris; Herman Goossens; Chantal Reusken; Marion Pg Koopmans; Christian Drosten Journal: Euro Surveill Date: 2020-01
Authors: Ulrich Terheggen; Christian Heiring; Mattias Kjellberg; Fredrik Hegardt; Martin Kneyber; Maurizio Gente; Charles C Roehr; Gilles Jourdain; Pierre Tissieres; Padmanabhan Ramnarayan; Morten Breindahl; Johannes van den Berg Journal: Pediatr Res Date: 2020-07-07 Impact factor: 3.756
Authors: Claudio Costantino; Emanuele Cannizzaro; Maria Gabriella Verso; Fabio Tramuto; Carmelo Massimo Maida; Guido Lacca; Davide Alba; Livia Cimino; Arianna Conforto; Luigi Cirrincione; Giorgio Graziano; Sara Palmeri; Stefano Pizzo; Vincenzo Restivo; Alessandra Casuccio; Francesco Vitale; Walter Mazzucco Journal: Front Public Health Date: 2021-05-13
Authors: Sean Wei Xiang Ong; Kristen K Coleman; Po Ying Chia; Koh Cheng Thoon; Surinder Pada; Indumathi Venkatachalam; Dale Fisher; Yian Kim Tan; Boon Huan Tan; Oon Tek Ng; Brenda Sze Peng Ang; Yee-Sin Leo; Michelle Su Yen Wong; Kalisvar Marimuthu Journal: Singapore Med J Date: 2020-07-30 Impact factor: 3.331
Authors: Monica Miranda-Schaeubinger; Einat Blumfield; Govind B Chavhan; Amy B Farkas; Aparna Joshi; Shawn E Kamps; Summer L Kaplan; Marla B K Sammer; Elizabeth Silvestro; A Luana Stanescu; Raymond W Sze; Danielle M Zerr; Tushar Chandra; Emily A Edwards; Naeem Khan; Eva I Rubio; Chido D Vera; Ramesh S Iyer Journal: Pediatr Radiol Date: 2020-07-07
Authors: Liang E Wee; Tzay-Ping Fua; Ying Y Chua; Andrew F W Ho; Xiang Y J Sim; Edwin P Conceicao; Indumathi Venkatachalam; Kenneth B-K Tan; Ban H Tan Journal: Acad Emerg Med Date: 2020-05-11 Impact factor: 3.451
Authors: Toi A Collins; Amanda E Sparks; Mary M Walker; Lon V Kendall; Karen M Dobos; Valerie K Bergdall; Judy M Hickman-Davis Journal: J Am Assoc Lab Anim Sci Date: 2021-06-25 Impact factor: 1.706